Streetbeat News

Price Targets

TYRA

Wedbush analyst Robert Driscoll has initiated coverage on Tyra Biosciences (NASDAQ:TYRA) with an Outperform rating and a price target of $27.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 8:55 am

BGNE

Bernstein analyst Rebecca Liang has downgraded BeiGene (NASDAQ:BGNE) from Outperform to Market Perform and lowered the price target from $335 to $196.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 8:53 am

IIPR

Piper Sandler analyst Alexander Goldfarb has downgraded Innovative Industrial Properties (NYSE:IIPR) from Overweight to Neutral and set a price target of $80.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 8:48 am

FSV

BMO Capital analyst Stephen MacLeod has upgraded FirstService (NASDAQ:FSV) from Market Perform to Outperform and raised the price target from $166 to $176.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 8:47 am

BDTX

Stifel analyst Bradley Canino has upgraded Black Diamond Therapeutic (NASDAQ:BDTX) from Hold to Buy and raised the price target from $2 to $10.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 8:45 am

NVDA

Daiwa Capital analyst Louis Miscioscia has upgraded NVIDIA (NASDAQ:NVDA) from Neutral to Outperform and raised the price target from $408 to $475.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 8:44 am

FRO

Deutsche Bank analyst Amit Mehrotra has upgraded Frontline (NYSE:FRO) from Hold to Buy, but lowered the price target from $19 to $17.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 8:41 am

STNG

Deutsche Bank analyst Amit Mehrotra has upgraded Scorpio Tankers (NYSE:STNG) from Hold to Buy and set a price target of $55.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 8:40 am

FRT

Piper Sandler analyst Alexander Goldfarb has upgraded Federal Realty Investment (NYSE:FRT) from Neutral to Overweight and set a price target of $111.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 8:39 am

CTM

EF Hutton analyst Edward Reilly has reiterated a 'Buy' rating on Castellum (AMEX:CTM) and maintained a price target of $1.4.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 8:37 am